Collateral Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Tuberculosis Control in Jiangsu Province, China-Reference-Cited by-同舟云学术

Collateral Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Tuberculosis Control in Jiangsu Province, China

Published:2020-08-28 Issue:3 Volume:73 Page:542-544
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Liu Qiao¹,Lu Peng¹,Shen Ye²^ORCID,Li Changwei²³^ORCID,Wang Jianming⁴,Zhu Limei¹,Lu Wei¹,Martinez Leonardo⁵

Affiliation:

1. Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, China

2. University of Georgia, College of Public Health, Department of Epidemiology and Biostatistics, Athens, Georgia, USA

3. Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA

4. Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China

5. Stanford University, School of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford, California, USA

Abstract

Abstract The coronavirus disease 2019 (COVID-19) pandemic may impede global tuberculosis elimination goals. In Jiangsu Province, China, tuberculosis notifications dropped 52% in 2020 compared to 2015–2019. Treatment completion and screening for drug resistance decreased continuously in 2020. Urgent attention must be paid to tuberculosis control efforts during and after the COVID-19 pandemic.

Funder

National Science and Technology Major Project

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa1289/34047595/ciaa1289.pdf

Reference17 articles.

1. The effect of tuberculosis control in China;China Tuberculosis Control Collaboration;Lancet,2004

2. Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data;Wang;Lancet,2014

3. The Italian health system and the COVID-19 challenge;Armocida;Lancet Public Health,2020